Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 21% ± 4% | |
epithelial cell | 3 studies | 30% ± 13% | |
dendritic cell | 3 studies | 25% ± 9% |
Insufficient scRNA-seq data for expression of NAA60 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3275.94 | 1445 / 1445 | 100% | 28.42 | 183 / 183 |
intestine | 100% | 4025.97 | 966 / 966 | 100% | 29.76 | 527 / 527 |
liver | 100% | 3884.27 | 226 / 226 | 100% | 30.04 | 406 / 406 |
ovary | 100% | 2777.15 | 180 / 180 | 100% | 21.23 | 430 / 430 |
pancreas | 100% | 2550.20 | 328 / 328 | 100% | 28.26 | 178 / 178 |
stomach | 100% | 4790.15 | 359 / 359 | 100% | 29.33 | 286 / 286 |
thymus | 100% | 3801.87 | 653 / 653 | 100% | 25.20 | 605 / 605 |
brain | 100% | 3392.48 | 2641 / 2642 | 100% | 32.56 | 705 / 705 |
prostate | 100% | 4080.15 | 245 / 245 | 100% | 44.73 | 501 / 502 |
uterus | 100% | 3144.02 | 170 / 170 | 100% | 28.80 | 458 / 459 |
lung | 100% | 3629.80 | 578 / 578 | 100% | 26.02 | 1151 / 1155 |
bladder | 100% | 3069.00 | 21 / 21 | 100% | 25.99 | 502 / 504 |
adrenal gland | 100% | 4583.58 | 258 / 258 | 100% | 27.08 | 229 / 230 |
skin | 100% | 2431.47 | 1808 / 1809 | 100% | 28.10 | 470 / 472 |
kidney | 100% | 5076.75 | 89 / 89 | 99% | 30.09 | 896 / 901 |
breast | 100% | 2840.41 | 459 / 459 | 99% | 31.64 | 1109 / 1118 |
adipose | 100% | 2723.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 19.85 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.80 | 29 / 29 |
spleen | 100% | 4701.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.57 | 1 / 1 |
blood vessel | 100% | 2938.28 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 2978.02 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1546.59 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3408.98 | 919 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008283 | Biological process | cell population proliferation |
GO_0007059 | Biological process | chromosome segregation |
GO_0006474 | Biological process | N-terminal protein amino acid acetylation |
GO_0017196 | Biological process | N-terminal peptidyl-methionine acetylation |
GO_0006334 | Biological process | nucleosome assembly |
GO_0000139 | Cellular component | Golgi membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0004596 | Molecular function | peptide alpha-N-acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NAA60 |
Protein name | histone acetyltransferase (EC 2.3.1.48) N-alpha-acetyltransferase 60, NatF catalytic subunit N-alpha-acetyltransferase 60 (hNaa60) (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF) N-alpha-acetyltransferase 60 (EC 2.3.1.259) (EC 2.3.1.48) (Histone acetyltransferase type B protein 4) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) |
Synonyms | HAT4 NAT15 UNQ2771/PRO7155 |
Description | FUNCTION: N-alpha-acetyltransferase that specifically mediates the acetylation of N-terminal residues of the transmembrane proteins, with a strong preference for N-termini facing the cytosol . Displays N-terminal acetyltransferase activity towards a range of N-terminal sequences including those starting with Met-Lys, Met-Val, Met-Ala and Met-Met . Required for normal chromosomal segregation during anaphase . May also show histone acetyltransferase activity; such results are however unclear in vivo and would require additional experimental evidences . . |
Accessions | I3L1B9 ENST00000360862.9 [Q9H7X0-3] ENST00000649360.1 [Q9H7X0-1] I3L2K7 ENST00000570372.5 I3L4Q3 ENST00000572942.5 [Q9H7X0-4] ENST00000572739.5 ENST00000573580.5 [Q9H7X0-3] ENST00000421765.7 [Q9H7X0-5] ENST00000573345.5 I3L205 ENST00000575076.5 [Q9H7X0-1] ENST00000577013.6 [Q9H7X0-3] ENST00000572169.6 [Q9H7X0-1] ENST00000576787.5 ENST00000575733.5 ENST00000574950.5 Q9H7X0 I3L2B4 I3L2M6 I3L4Q5 I3L153 ENST00000572584.2 [Q9H7X0-1] ENST00000572131.5 ENST00000573593.5 I3L1X5 I3L4T5 ENST00000424546.6 [Q9H7X0-2] ENST00000570819.5 [Q9H7X0-4] ENST00000407558.9 [Q9H7X0-1] ENST00000649205.1 [Q9H7X0-1] ENST00000414063.6 [Q9H7X0-1] ENST00000576916.5 I3L1T4 ENST00000574328.5 ENST00000572757.5 |